Trial Profile
A Multicenter, Pragmatic Randomized, Double-blind, Placebo-controlled Trial of Xuezhikang Capsule for Treating Dyslipidemia: a Postmarketing Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Mar 2014
Price :
$35
*
At a glance
- Drugs Monascus (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- 11 Mar 2014 New trial record